Informatie:
Fout:
ID
22845
Beschrijving
Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents; ODM derived from: https://clinicaltrials.gov/show/NCT00598715
Link
https://clinicaltrials.gov/show/NCT00598715
Trefwoorden
Versies (1)
- 13-06-17 13-06-17 -
Geüploaded op
13 juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Coronary Artery Disease NCT00598715
Eligibility Coronary Artery Disease NCT00598715
- StudyEvent: Eligibility
Similar models
Eligibility Coronary Artery Disease NCT00598715
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
patients older than age 18 with ischemic symptoms or evidence of myocardial ischemia in the presence of > 50% re- stenosis after prior implantation of sirolimus eluting stents in native coronary vessels
boolean
C0001779 (UMLS CUI [1,1])
C0151744 (UMLS CUI [1,2])
C0333186 (UMLS CUI [1,3])
C0151744 (UMLS CUI [1,2])
C0333186 (UMLS CUI [1,3])
ID.2
Item
written, informed consent by the patient or her/his legally-authorized representative for participation in the study
boolean
C0021430 (UMLS CUI [1])
ID.3
Item
in women with childbearing potential a negative pregnancy test is mandatory
boolean
C0427780 (UMLS CUI [1])
ID.4
Item
cardiogenic shock
boolean
ID.5
Item
acute myocardial infarction within the first 48 hours from symptom onset.
boolean
C0155626 (UMLS CUI [1])
ID.6
Item
target lesion located in the left main trunk or bypass graft.
boolean
C2184261 (UMLS CUI [1,1])
C0741847 (UMLS CUI [1,2])
C0226031 (UMLS CUI [1,3])
C0741847 (UMLS CUI [1,2])
C0226031 (UMLS CUI [1,3])
ID.7
Item
malignancies or other comorbid conditions (for example severe liver, renal and pancreatic disease) with life expectancy less than 12 months or that may result in protocol non-compliance.
boolean
C1275743 (UMLS CUI [1,1])
C1504437 (UMLS CUI [1,2])
C1504437 (UMLS CUI [1,2])
ID.8
Item
allergy to antiplatelet therapy, sirolimus, paclitaxel, stainless steel.
boolean
C0020517 (UMLS CUI [1])
ID.9
Item
pregnancy (present, suspected or planned) or positive pregnancy test.
boolean
C0032961 (UMLS CUI [1,1])
C0240802 (UMLS CUI [1,2])
C0240802 (UMLS CUI [1,2])
ID.10
Item
previous enrollment in this trial.
boolean
C0205156 (UMLS CUI [1,1])
C1516879 (UMLS CUI [1,2])
C1516879 (UMLS CUI [1,2])
ID.11
Item
patient's inability to fully comply with the study protocol.
boolean
C1321605 (UMLS CUI [1])